Table of Contents

2019-2024 Global Latanoprost Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Latanoprost Consumption 2014-2024
  • 2.1.2 Latanoprost Consumption CAGR by Region
• 2.2 Latanoprost Segment by Type
  • 2.2.1 Brand Drug
  • 2.2.2 Generic Drug
• 2.3 Latanoprost Consumption by Type
  • 2.3.1 Global Latanoprost Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Latanoprost Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Latanoprost Sale Price by Type (2014-2019)
• 2.4 Latanoprost Segment by Application
  • 2.4.1 Open-angle Glaucoma
  • 2.4.2 Close-angle Glaucoma
• 2.5 Latanoprost Consumption by Application
  • 2.5.1 Global Latanoprost Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Latanoprost Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Latanoprost Sale Price by Application (2014-2019)

3 Global Latanoprost by Players

• 3.1 Global Latanoprost Sales Market Share by Players
  • 3.1.1 Global Latanoprost Sales by Players (2017-2019)
  • 3.1.2 Global Latanoprost Sales Market Share by Players (2017-2019)
• 3.2 Global Latanoprost Revenue Market Share by Players
  • 3.2.1 Global Latanoprost Revenue by Players (2017-2019)
  • 3.2.2 Global Latanoprost Revenue Market Share by Players (2017-2019)
• 3.3 Global Latanoprost Sale Price by Players
• 3.4 Global Latanoprost Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Latanoprost Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Latanoprost Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Latanoprost by Regions

• 4.1 Latanoprost by Regions
  • 4.1.1 Global Latanoprost Consumption by Regions
  • 4.1.2 Global Latanoprost Value by Regions
• 4.2 Americas Latanoprost Consumption Growth
• 4.3 APAC Latanoprost Consumption Growth
• 4.4 Europe Latanoprost Consumption Growth
• 4.5 Middle East & Africa Latanoprost Consumption Growth

5 Americas

• 5.1 Americas Latanoprost Consumption by Countries
  • 5.1.1 Americas Latanoprost Consumption by Countries (2014-2019)
  • 5.1.2 Americas Latanoprost Value by Countries (2014-2019)
• 5.2 Americas Latanoprost Consumption by Type
• 5.3 Americas Latanoprost Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Latanoprost Consumption by Countries
  • 6.1.1 APAC Latanoprost Consumption by Countries (2014-2019)
  • 6.1.2 APAC Latanoprost Value by Countries (2014-2019)
• 6.2 APAC Latanoprost Consumption by Type
• 6.3 APAC Latanoprost Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Latanoprost by Countries
  • 7.1.1 Europe Latanoprost Consumption by Countries (2014-2019)
  • 7.1.2 Europe Latanoprost Value by Countries (2014-2019)
• 7.2 Europe Latanoprost Consumption by Type
• 7.3 Europe Latanoprost Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Latanoprost by Countries
  • 8.1.1 Middle East & Africa Latanoprost Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Latanoprost Value by Countries (2014-2019)
• 8.2 Middle East & Africa Latanoprost Consumption by Type
• 8.3 Middle East & Africa Latanoprost Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Latanoprost Distributors
• 10.3 Latanoprost Customer

11 Global Latanoprost Market Forecast

• 11.1 Global Latanoprost Consumption Forecast (2019-2024)
• 11.2 Global Latanoprost Forecast by Regions
  • 11.2.1 Global Latanoprost Forecast by Regions (2019-2024)
  • 11.2.2 Global Latanoprost Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Latanoprost Forecast by Type
• 11.8 Global Latanoprost Forecast by Application

12 Key Players Analysis

• 12.1 Pfizer
  • 12.1.1 Company Details
  • 12.1.2 Latanoprost Product Offered
  • 12.1.3 Pfizer Latanoprost Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Pfizer News
• 12.2 Mylan
  • 12.2.1 Company Details
  • 12.2.2 Latanoprost Product Offered
  • 12.2.3 Mylan Latanoprost Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Mylan News
• 12.3 Novartis
  • 12.3.1 Company Details
  • 12.3.2 Latanoprost Product Offered
  • 12.3.3 Novartis Latanoprost Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Novartis News
• 12.4 Apotex
  • 12.4.1 Company Details
  • 12.4.2 Latanoprost Product Offered
  • 12.4.3 Apotex Latanoprost Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Apotex News
• 12.5 Teva
  • 12.5.1 Company Details
  • 12.5.2 Latanoprost Product Offered
  • 12.5.3 Teva Latanoprost Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Teva News
• 12.6 Taj Pharma
  • 12.6.1 Company Details
  • 12.6.2 Latanoprost Product Offered
  • 12.6.3 Taj Pharma Latanoprost Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Taj Pharma News
• 12.7 CR Zizhu
  • 12.7.1 Company Details
  • 12.7.2 Latanoprost Product Offered
  • 12.7.3 CR Zizhu Latanoprost Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 CR Zizhu News

...

13 Research Findings and Conclusion

Latanoprost drops is a clear colorless liquid and a medication used to treat increased pressure inside the eye. Onset of effects is usually within four hours, and they last for up to a day.
Latanoprost is widely used in the treatment of Open-angle Glaucoma and Closed-angle Glaucoma. The most proportion of Latanoprost is Open-angle Glaucoma, and the sales market share in 2016 is about 82%.
North America is the largest supplier and Europe is in the second place of production market with market share of 36.5% and 28.9%. On the other hand, North America and Europe are also the top 2 consumption market with market share of 36.3% and 20.5%.

According to this study, over the next five years the Latanoprost market will register a 2.3% CAGR in terms of revenue, the global market size will reach US$ 1440 million by 2024, from US$ 1260 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Latanoprost business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Latanoprost market by product type, application, key manufacturers and key regions and countries.

This study considers the Latanoprost value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Brand Drug
Generic Drug
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Open-angle Glaucoma
Close-angle Glaucoma

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Pfizer
Mylan
Novartis
Apotex
Teva
Taj Pharma
CR Zizhu
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Latanoprost consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Latanoprost market by identifying its various subsegments.
Focuses on the key global Latanoprost manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Latanoprost with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Latanoprost submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.